PMV Pharmaceuticals, Inc.
PMVPDrugs in Pipeline
1
Phase 3 Programs
0
Upcoming Catalysts
0
Next Catalyst
None scheduled
Market Overview
Stock performance and key metrics
0 upcoming, 2 past
No catalysts found.
How PMVP's past catalysts played out
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
rezatapopt | Phase 2 | Advanced Solid Tumor | - | - |
Frequently asked questions
What is in PMV Pharmaceuticals, Inc.'s drug pipeline?→
CatalystAlert tracks 1 drug candidate in PMV Pharmaceuticals, Inc.'s (PMVP) pipeline across Phase 2. Its lead program is rezatapopt (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PMV Pharmaceuticals, Inc.'s next FDA catalyst?→
CatalystAlert tracks every upcoming catalyst for PMV Pharmaceuticals, Inc. (PMVP) — PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings — each confidence-rated as confirmed, estimated or AI-detected.
How do I track PMVP biotech catalysts?→
Add PMVP to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PMV Pharmaceuticals, Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.